Cytostatic and apoptotic effects of paclitaxel in human breast tumors

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s002800050803PMID 9685052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines

  2004cited by this paper
• The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell lines

  2004cited by this paper
• Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

  2004cited by this paper
• Pharmacologic effects of paclitaxel in human bladder tumors

  1997cited by this paper
• Time-dependent taxol cytotoxicity

  1997cited by this paper
• Differential time dependency of antiproliferative and apoptotic effects of taxol in human prostate tumors.

  1997cited by this paper
• Pharmacodynamics of taxol in human head and neck tumors.

  1996cited by this paper
• Binding of taxol to plastic and glass containers and protein under in vitro conditions.

  1996cited by this paper
• Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

  1996cited by this paper
• The role of taxanes in the treatment of breast cancer.

  1996cited by this paper
• Clinical applications of the histoculture drug response assay.

  1995cited by this paper
• Potential of the histoculture drug-response assay to contribute to cancer patient survival.

  1995cited by this paper
• Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

  1995cited by this paper
• Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle

  1994cited by this paper
• Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin.

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines

  1994cited by this paper
• Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?

  1994cited by this paper
• Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line.

  1994cited by this paper
• Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques.

  1994cited by this paper
• Apoptotic cell death during treatment of leukemias.

  1994cited by this paper
• Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.

  1993cited by this paper
• Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.

  1993cited by this paper
• The clinical pharmacology of paclitaxel (Taxol).

  1993cited by this paper
• Taxol sensitizes human astrocytoma cells to radiation.

  1992cited by this paper
• Development of polyploidization in taxol-resistant human leukemia cells in vitro.

  1990cited by this paper
• In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.

  1987cited by this paper
• Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

  1987influential reference
• Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor.

  1981cited by this paper

• Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen

  2022cites this paper
• Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?

  2018cites this paper
• Nanotechnology for cancer therapy

  2016cites this paper
• Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B.

  2013cites this paper
• Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer

  2012cites this paper
• ER−/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection

  2012cites this paper
• Current and Next Generation Antimitotic Therapies in Cancer

  2012cites this paper
• Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

  2011cites this paper
• Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays

  2011cites this paper
• Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3′-deoxy-3′-[18F]fluorothymidine in preclinical tumor models

  2011cites this paper
• Cancer Therapy : Preclinical Characterization of Alisertib ( MLN 8237 ) , an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays

  2011cites this paper
• Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.

  2011influential citation
• Translational Research: Using Suramin as a Platform

  2010cites this paper
• Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

  2009cites this paper
• Tumor Priming Enhances Delivery and Efficacy of Nanomedicines

  2007cites this paper
• Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

  2002cites this paper
• Evaluation of a Gemcitabine‐Doxorubicin‐Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines

  2002cites this paper
• Mdr1 Transfection Causes Enhanced Apoptosis by Paclitaxel: An Effect Independent of Drug Efflux Function of P-Glycoprotein

  2001cites this paper
• Risks and Benefits of Taxanes in Breast and Ovarian Cancer

  2000cites this paper
• TP 53 Mutation and p 53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients 1

  2000cites this paper
• TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

  2000cites this paper
• Resistance to paclitaxel induces time-delayed multinucleation and DNA fragmentation into large fragments in MCF-7 human breast adenocarcinoma cells

  2000cites this paper
• Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.

  1999cites this paper
• Relationship between paclitaxel activity and pathobiology of human solid tumors.

  1998cites this paper